Results 121 to 130 of about 27,020 (235)

Antibiotic Consumption Patterns in Urban Coari, Amazonas: High Azithromycin Use and COVID-19-Related Prescriptions

Pharmacoepidemiology
Background/Objectivses: Antibiotic consumption patterns in remote urban areas of the Amazon region are poorly understood. This study aimed to analyze antibiotic use in the adult population of Coari, a municipality in Amazonas, Brazil.
Rodrigo Silva Marcelino, Edivã Bernardo da Silva, Abel Santiago Muri Gama, Ananias Facundes Guimarães, Silvia Regina Secoli, Albert Figueras   +5 more
doaj   +1 more source

Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real‐world data

British Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3950-3958, November 2026.
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon, Wendy Wang, Faye L. Norby, Rob F. Walker, Shalini Kulasingam, Lisa S. Chow, Joel F. Farley, Pamela L. Lutsey   +7 more
wiley   +1 more source

A Systematic Review of Potential Opioid Prescribing Safety Indicators

Pharmacoepidemiology
Background/Objectives: This systematic review aimed to identify a comprehensive list of potential opioid-related indicators from the published literature to assess prescribing safety in any setting.
Wael Y. Khawagi, Neetu Bansal, Nan Shang, Li-Chia Chen   +3 more
doaj   +1 more source

Migalastat Versus Enzyme Replacement Therapy in Treatment‐Naïve Fabry Disease: Real‐World Evidence From the followME Fabry Pathfinders Registry

Journal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Fabry disease is a rare, progressive, X‐linked disease resulting from α‐galactosidase A enzyme deficiency due to GLA gene variants. Current treatments include intravenous enzyme replacement therapy (ERT) and the oral pharmacologic chaperone migalastat.
Peter Nordbeck, Agnieszka Kopiec, Noemi Hummel, Vera Gielen, Biliana O. Veleva‐Rotse, Alasdair MacCulloch   +5 more
wiley   +1 more source

Interventional pharmacoepidemiology: design and evaluation of interventions to improve prescribing [PDF]

Despite the value of modern therapeutics, many obstacles prevent their optimal use. Overuse, underuse and misuse are common, resulting in morbidity and mortality impacting billions of individuals across the world.
Grant, Aileen, Dreischulte, Tobias, Hughes, Carmel, Alexander, G. Caleb   +3 more
core   +1 more source

Dermatological Disease at a Tertiary Military Hospital in Burundi: A Retrospective Review

International Journal of Dermatology, EarlyView.
Doriane Sabushimike, Alison K. Wright, Marc Nimburanira, Patrick Budengeri, Christopher E. M. Griffiths, Darren M. Ashcroft   +5 more
wiley   +1 more source

Temporal Trends in Janus Kinase Inhibitor (JAKi) Use Across Five European Countries: A DARWIN EU Network Study

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Introduction Janus kinase inhibitors (JAKi) are increasingly used for autoimmune conditions despite existing safety concerns. This study aims to estimate the incidence of new JAKi use over time and characterise users in Europe to support future safety studies.
Xihang Chen, Andrei Barbulescu, George Corby, Saeed Hayati, Annika Jodicke, Toni Lehtonen, Hedvig Marie Egeland Nordeng, Alexandra Pacurariu, Gabriel Sanfélix‐Gimeno, Nhung T. H. Trinh, Katia Verhamme, Dina Vojinovic, Daniel Prieto‐Alhambra, Amy Shuk‐Man Lam, Edward Burn   +14 more
wiley   +1 more source

Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Purpose The COVID‐19 pandemic disrupted healthcare services, potentially affecting causal effect estimation using real‐world data. As a case study, we replicated a cohort study using Clinical Practice Research Datalink Aurum to evaluate whether pandemic‐related disruptions influenced the measured association between fluoroquinolone use and ...
Angel Y. S. Wong, Jeremy P. Brown, John Tazare, Marleen Bokern, Elizabeth Williamson, Jonathan Bartlett, Charlotte Warren‐Gash, Ian Douglas   +7 more
wiley   +1 more source

Core concepts in pharmacoepidemiology: multi-database distributed data networks [PDF]

Multi-database distributed data networks for post-marketing surveillance of drug safety and effectiveness use two main approaches: common data models (CDMs) and common protocols. Networks such as the U.S.
Prieto-Alhambra, Daniel, Haber, Rachelle, Maro, Judith C., Prieto-Alhambra, D., Li, X., Platt, Robert W., Filion, Kristian B., Maro, J.C., Haber, R., Barclay, N., Li, Xue, Platt, R.W., Webster-Clark, Michael, Pratt, Nicole, Webster-Clark, M., Filion, K.B., Barclay, Nicola, Pratt, N.   +17 more
core   +1 more source

Cancer Treatment During Pregnancy and Maternal and Infant Outcomes: A Descriptive Cohort Study Using a Japanese Claims Database

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Purpose To characterize cancer treatment during pregnancy and maternal and infant outcomes among women with cancer identified during pregnancy in Japan. Methods In this descriptive cohort study, we used mother‐infant linkage data from the JMDC claims database from 2005 to 2024.
Masami Tsuchiya, Tomofumi Ishikawa, Takamasa Sakai, Satoko Hori, Taku Obara   +4 more
wiley   +1 more source